Clinical Trials - April 1, 2015
Antipsychotic Shows Promise
Three-month paliperidone palmitate, an investigational atypical antipsychotic developed by Janssen Research & Development, LLC, significantly delayed relapse time compared with a placebo in patients with schizophrenia, according to a new Phase 3 clinical study recently published in the Journal of the American Medical Association (JAMA) Psychiatry. Results of the study served as the basis for […]
Clinical Trials - April 1, 2015
Liver Disease Drug Trial Starts
Biotie Therapies Corp. of Finland has started patient enrollment into the Phase 2a clinical study evaluating BTT1023, Biotie’s fully human monoclonal antibody targeting Vascular Adhesion Protein-1, in primary sclerosing cholangitis (PSC). PSC is a progressive disease characterized by bile duct inflammation and fibrosis, and accompanying hepatic fibrosis, that frequently results in the need for a […]
Uncategorized - March 31, 2015
Robots Sort, Distribute Drugs
Pharmacies and other institutions now can use robots and automatic storage systems to speed the organization and retrieval of drugs and reduce errors. Finnish firm New Icon created sorting robots and storage systems in which robot arms are able to identify drugs and put them in the right storage slot as well as retrieve them […]
Pharma Business - March 30, 2015
Karolinska Sells Axelar Shares
Karolinska Development AB has sold its shares in Axelar AB to The Foundation for Baltic and East European Studies (Östersjöstiftelsen). The agreement is in keeping with Karolinska Development’s current strategy. “Karolinska Development’s new strategy includes focusing on our strategic portfolio, an increased emphasis on leadership within our portfolio companies, proactively syndicating our investments with […]
Clinical Trials - March 30, 2015
Clanotech Drug Gets FDA Orphan Label
Clanotech AB’s candidate drug CLT-28643 has received orphan drug designation by the U.S. Food and Drug Administration (FDA) for prevention of scarring after glaucoma surgery. The European Medicines Agency (EMA) previously granted an orphan drug designation pertaining to the EU. The orphan drug designation is expected to significantly shorten future market approval processes and reinforce […]
Uncategorized - March 30, 2015
Gene Variants Affect Brain Size
Researchers at the University of Oslo have identified several new gene variants that affect the size of the human brain. The newly-identified variants are important for the brain’s development, the removal of unwanted cells and for contact between nerve cells, according to the University of Oslo. “This is an important step on the path to […]
